BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.
- DOI
- 10.4143/crt.2018.598
- Published
- 2019 Oct
- Container
- Cancer research and treatment
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4143/crt.2018.598,
title = {BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.},
author = {Kim SB and Do IG and Tsang J and Kim TY and Yap YS and Cornelio G and Gong G and Paik S and Lee S and Ng TY and Park S and Oh HS and Chiu J and Sohn J and Lee M and Choi YJ and Lee EM and Park KH and Nathaniel C and Ro J},
year = {2019},
journal = {Cancer research and treatment},
doi = {10.4143/crt.2018.598},
url = {https://doi.org/10.4143/crt.2018.598}
}RIS
TY - JOUR TI - BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy. AU - Kim SB AU - Do IG AU - Tsang J AU - Kim TY AU - Yap YS AU - Cornelio G AU - Gong G AU - Paik S AU - Lee S AU - Ng TY AU - Park S AU - Oh HS AU - Chiu J AU - Sohn J AU - Lee M AU - Choi YJ AU - Lee EM AU - Park KH AU - Nathaniel C AU - Ro J PY - 2019 JO - Cancer research and treatment DO - 10.4143/crt.2018.598 UR - https://doi.org/10.4143/crt.2018.598 ER -
APA
SB, K., IG, D., J, T., TY, K., YS, Y., G, C., G, G., S, P., S, L., TY, N., S, P., HS, O., J, C., J, S., M, L., YJ, C., EM, L., KH, P., C, N., & J, R. (2019). BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy.. Cancer research and treatment. https://doi.org/10.4143/crt.2018.598
Source records
- pubmed · retrieved 2026-09-25T23:38:49.703Z